LIQOMICS

At LIQOMICS we strive to improve cancer treatment. Requiring only a blood sample, we use circulating tumor DNA to understand the genetics of an individual cancer and monitor treatment with razor-sharp sensitivity. We aspire to bring our cutting-edge liquid biopsy technology for genotyping and disease monitoring to patients worldwide.